Gene · 810
CALML3: calmodulin like 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CALML3: calmodulin like 3. Genes, record 810. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/810
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P27482 | Calmodulin-like protein 3 | 149 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents24
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 39768 | P27482 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 11065 | P27482 | Espacenet |
| US 11988676 B2 | 2024-05-21 | 17 | P27482 | Espacenet |
| JP 2024038290 A | 2024-03-19 | 17 | P27482 | Espacenet |
| JP 2023531521 A | 2023-07-24 | 17 | P27482 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 11065 | P27482 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 114036 | P27482 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 1538 | P27482 | Espacenet |
| JP 2021503610 A | 2021-02-12 | 17 | P27482 | Espacenet |
| EP 3710836 A1 | 2020-09-23 | 17 | P27482 | Espacenet |
1 to 10 of 24
See all 24 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants882
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CALML3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P50CA116201 | Mayo Clinic Breast Cancer SPORE | 5 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 3 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 3 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 3 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 3 | 2025 |
| P50CA136393 | Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancer | 3 | 2025 |
| U10CA180868 | NRG Oncology Network Group Operations Center | 3 | 2025 |
| P01HL114501 | Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers | 2 | 2025 |
1 to 10 of 882Source NIH's project files
See all 882 nih grantsPapers1,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The influence and impact of human relevance in (CLP) classification for human health hazard endpoints. | Regul Toxicol Pharmacol | 2026 | 42700812 | PubTator, text mining | PubMed |
| Expertise-driven differences in drummers' wrist-muscle motor unit behaviour. | Sci Rep | 2026 | 42509324 | PubTator, text mining | PubMed |
| Genomic insights into antagonistic coevolution: collagen-like protein expansion and genome plasticity in the Daphnia parasite Pasteuria ramosa. | G3 (Bethesda) | 2026 | 41968091 | PubTator, text mining | PubMed |
| Chitinase-like proteins de-N-glycosylating CD36 modify cholesterol metabolism in atherosclerotic macrophages. | Nat Commun | 2026 | 41951645 | PubTator, text mining | PubMed |
| Occupational Exposure to Resorcinol and Thyroid-Disrupting Effects: Protocol for an Exploratory Field Study in French Hairdressers. | JMIR Res Protoc | 2026 | 41915798 | PubTator, text mining | PubMed |
| Predictability beyond accuracy: A correlation-based evaluation of survey forecasts of the Chilean exchange rate. | PLoS One | 2026 | 41894419 | PubTator, text mining | PubMed |
| Proteomic Analysis in Search of New Biomarkers of Immune Thrombocytopenia (ITP)-A Review of Current Data. | Proteomes | 2026 | 41893727 | PubTator, text mining | PubMed |
| A Sensitive Real-Time PCR-Based Assay for the Identification of Colletotrichum in Phytosanitary and Clinical Applications. | J Fungi (Basel) | 2026 | 41893103 | PubTator, text mining | PubMed |
| Calmodulin-like protein condensates decode PAMP-induced nuclear calcium to activate plant immunity. | Cell Rep | 2026 | 41849347 | PubTator, text mining | PubMed |
| Methylation signatures distinguish non-small cell lung cancer subtypes and are associated with survival in smokers with lung squamous cell carcinoma. | J Natl Cancer Inst | 2026 | 41808476 | PubTator, text mining | PubMed |
1 to 10 of 1,328
See all 1,328 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/810
GET https://conductscience.org/api/genes/v1/810/patents?page=2